One Chip, One Genome

Microarray density continues to climb. In the past year, several companies have compressed the entire protein-coding portion of the human genome onto a single chip – that's some 30,000 to 40,000 unique gene sequences per slide. One company has reduced its arrays to the size of microtiter-plate wells, for use in high-throughput biochip analysis. And arrays to genotype 100,000 single nucleotide polymorphisms (SNPs) at once have also come to market."In the next few months, you're going to see

Written byEmma Hitt
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Microarray density continues to climb. In the past year, several companies have compressed the entire protein-coding portion of the human genome onto a single chip – that's some 30,000 to 40,000 unique gene sequences per slide. One company has reduced its arrays to the size of microtiter-plate wells, for use in high-throughput biochip analysis. And arrays to genotype 100,000 single nucleotide polymorphisms (SNPs) at once have also come to market.

"In the next few months, you're going to see more and more people doing experiments where they're interrogating the whole human genome in one experiment," predicts Gary Hardiman, director of the Biomedical Genomics Microarray Facility at the University of California, San Diego. Hardiman says human whole-genome experiments will be most useful for researchers trying to identify new biological pathways rather than for those looking in depth at smaller gene sets.

According to Mark Schena, who coauthored a seminal 1995 paper ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies